By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Patheon Inc. 

4815 Emperor Boulevard
Suite 300
Durham  North Carolina  27703-8580   U.S.A.
Phone: 919-226-3200 or 866 728 4366 Fax: n/a

Patheon Inc. (TSX: PTI) is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry. The company provides the highest quality products and services to approximately 300 of the world’s leading pharmaceutical and biotechnology companies. Its services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, soft gel, solid and liquid forms.

The company’s comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. The company’s integrated development and manufacturing network of nine manufacturing facilities, nine development centers and one clinical trial material packaging facility across North America and Europe, enables customer products to be launched with confidence anywhere in the world.

Key Statistics

Ownership: Public

Web Site: Patheon
Employees: 4,000
Symbol: PTHN


Company News
Did Patheon (PTHN) Get Enough In Its Buyout? 5/16/2017 6:23:12 AM
Thermo Fisher Scientific (TMO) Bags Patheon (PTHN) in $7.2 Billion Deal, Pantheon Stock Soars 5/15/2017 5:52:30 AM
Patheon (PTHN) Completes Sterile Expansion Project At Greenville, NC Manufacturing Site 5/8/2017 6:28:38 AM
Patheon (PTHN) Achieved More Outsourced New Drug Approvals Than Any Other Provider According To 2017 PharmSource CMO Scorecard 3/30/2017 7:06:37 AM
Patheon (PTHN) Reports Fiscal 2017 First Quarter Results 3/16/2017 7:35:54 AM
Patheon (PTHN) To Announce First Quarter Fiscal Year 2017 Financial Results On March 16, 2017 3/3/2017 7:16:27 AM
Patheon (PTHN) Named Supply Chain Resiliency Partner Of The Year 3/2/2017 7:38:48 AM
This Can Be Patheon (PTHN)'s Fate in Trump's Call for Increased Drug Production 2/3/2017 7:07:23 AM
Patheon (PTHN) Announces Completion Of Its Acquisition Of State-of-the-Art Manufacturing Site 2/1/2017 8:14:46 AM
Patheon (PTHN) Reports Growth Across All Segments For Fourth Quarter; Provides Outlook For Fiscal Year 2017 12/20/2016 10:51:54 AM